Patents/Inventors

Maria Soraya Carrancio Anton

San Diego, CAUS9 patents

8 Patents

US125105332025
Methods for Treating Multiple Myeloma and the Use of Companion Biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile
Celgene Corporation
0 cites
US123969952025
Substituted 4-aminoisoindoline-1,3-dione Compounds and Second Active Agents for Combined Use
Celgene Corporation
0 cites
US123576212025
BET Inhibitors as a Treatment for Myelofibrosis
0 cites
US121788222024
Methods of Treating Hematological Malignancies Using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dion
Celgene Corporation
0 cites
US121039232024
Methods of Treating Non-hodgkin Lymphoma Using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione
Celgene Corporation
0 cites
US117260802023
Methods for Treating Multiple Myeloma and the Use of Companion Biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile
Celgene Corporation
0 cites
US116665792023
Methods of Treating Hematological Malignancies Using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione
Celgene Corporation
0 cites
US115835362023
Substituted 4-aminoisoindoline-1,3-dione Compounds and Second Active Agents for Combined Use
Celgene Corporation
0 cites